Made its first investment from Mérieux Innovation 2 in deepull, a diagnostics company.
Deepull is a medical diagnostics company developing culture-free diagnostic solutions for sepsis and acute infections, aiming to provide rapid and accurate pathogen identification directly from blood samples
Deepull is a medical diagnostics company developing culture-free diagnostic solutions for sepsis and acute infections, aiming to provide rapid and accurate pathogen identification directly from blood samples.